FDA.reportPublic FDA data

Omvoh 300 MG per 15 ML Injection

RxCUI
2668398
RxNorm name
Omvoh 300 MG per 15 ML Injection
Display name
Omvoh 300 MG per 15 ML Injection
Full name
Omvoh 300 MG per 15 ML Injection
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:38:56

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
761279Omvohmirikizumab-mrkz351(a)Rx2026-06-01

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
472cbe04-263e-433d-9a0f-58c1b50b715aOmvoh 300 MG per 15 ML InjectionSY18These highlights do not include all the information needed to use OMVOH safely and effectively. See full prescribing information for OMVOH. OMVOH (mirikizumab-mrkz) injection, for intravenous or subcutaneous use Initial U.S. Approval: 202320251104
472cbe04-263e-433d-9a0f-58c1b50b715aomvoh 300 MG in 15 ML InjectionPSN18These highlights do not include all the information needed to use OMVOH safely and effectively. See full prescribing information for OMVOH. OMVOH (mirikizumab-mrkz) injection, for intravenous or subcutaneous use Initial U.S. Approval: 202320251104
472cbe04-263e-433d-9a0f-58c1b50b715a15 ML Omvoh 20 MG/ML InjectionSY18These highlights do not include all the information needed to use OMVOH safely and effectively. See full prescribing information for OMVOH. OMVOH (mirikizumab-mrkz) injection, for intravenous or subcutaneous use Initial U.S. Approval: 202320251104
472cbe04-263e-433d-9a0f-58c1b50b715a15 ML mirikizumab-mrkz 20 MG/ML Injection [Omvoh]SBD18These highlights do not include all the information needed to use OMVOH safely and effectively. See full prescribing information for OMVOH. OMVOH (mirikizumab-mrkz) injection, for intravenous or subcutaneous use Initial U.S. Approval: 202320251104